Federal health officials have given approval to a new insulin injection designed to help adults with type 2 diabetes better manage their blood sugar levels. The treatment, called Awiqli, was developed by pharmaceutical company Novo Nordisk.
Federal health regulators have given the thumbs up to a new insulin treatment designed to help adults with type 2 diabetes better control their blood sugar levels.
Novo Nordisk announced Thursday that the Food and Drug Administration has granted approval for their insulin injection called Awiqli. The medication is specifically intended for adult patients diagnosed with type 2 diabetes who need help managing their glucose levels.
The pharmaceutical company’s announcement came on Thursday following the federal agency’s decision to clear the treatment for use in the United States.